Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Pre-Close Trading Update

28 Apr 2026 07:00

RNS Number : 1040C
Symphony Environmental Tech. PLC
28 April 2026
 

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

28 April 2026

 

Symphony Environmental Technologies plc

("Symphony", the "Company" or the "Group")

FY-2025 pre-close trading update and

 

Strong start to FY-2026 - first half profitability

 

Symphony Environmental Technologies plc ("Symphony" or the "Group"); global specialists in technologies that make plastic and rubber products "smarter, safer and sustainable", is pleased to provide the following pre-close trading update for the year ended 31 December 2025 ("FY-2025") and notice of FY-2025 results, together with a trading update for the current year to date.

FY2025 trading update (subject to audit)

Further to the Company's announcement on 17 December 2025, the Board now expects that, as a result of management‑driven strategic change in its Middle East operations, Group revenue for FY-2025 will be higher than previously guided, at approximately £5.7 million, with an adjusted loss before interest, tax, depreciation and amortisation ("adjusted LBITDA") broadly comparable to that incurred in the prior year, at approximately £0.9 million.

Importantly, and as further set out below, sales momentum has not just continued but accelerated during the first four months of FY-2026, running at more than 10 per cent. ahead of the same period last year. Furthermore, margins are also improving due to operational leverage as well as the positive impact of strategic initiatives taken during FY-2025, in particular in the Middle East.

In addition to the above adjusted LBITDA, the following one-off costs were incurred during FY-2025 as well as certain asset provisions will be made to the FY-2025 results:

· Strategic costs of £500,000 primarily in relation to the Middle East but also of certain future corporate initiatives;

· Impairment provision of £468,000 against development costs for the Group's antimicrobial products due to extended South American customer trials and commercial evaluation; and

· Other investment provisions of £107,000.

 

 

The net loss including provisions and strategic costs for FY-2025 is expected to be £2.5 million (FY-2024: £1.3 million).

The Board expects to announce its preliminary results for FY-2025 during the latter half of May.

Outlook

The Board remains focused on margin quality, disciplined cost control and the commercialisation of higher‑value technologies, rather than short‑term volume growth.

That said, it is particularly pleasing that trading in the first four months of 2026 has improved materially. The Group delivered a positive EBITDA in Q1-2026, compared with a loss in the corresponding prior‑year and based on current order patterns, expects to deliver a net profit for H1-2026.

Revenues are currently tracking more than 10 per cent ahead of the same period last year. Confirmed orders have been received across all principal markets, particularly Central America. While the timing of shipments remains subject to customer scheduling and customary operational factors, the Board is encouraged by the visibility and quality of the pipeline now in place, which underpins its confidence in the Group's earnings trajectory.

The Group continues to monitor the evolving geopolitical situation in the Middle East, which to date has not had a material adverse effect on operations.

Enquiries:

Symphony Environmental Technologies Plc

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

www.symphonyenvironmental.com

Zeus (Nominated Adviser and Broker)

David Foreman, Emma Burn (Investment Banking)

Tel: +44 (0) 203 829 5000

NOTES TO EDITORS

 

 

About Symphony Environmental

 

 

Symphony's d2w masterbatch technology is added to polyethylene (PE) and polypropylene (PP) products at the manufacturing stage at little or no extra cost, and ensures that if they get into the environment at the end of their useful life they will not create microplastics and lie or float around for decades. https://www.symphonyenvironmental.com/technologies/biodegradable-plastic/ Instead they will safely biodegrade, leaving no microplastics or toxicity.

 

If they get collected during their programmed life they can be recycled with ordinary PE and PP without separation See https://www.biodeg.org/subjects-of-interest/recycling-2/

 

Symphony also supplies a range of plastic technologies under its d2p (designed to protect) brand www.d2p.net to provide protection against insects, viruses, bacteria, fungi, rodents, odours, and fire. 

 

It has also introduced a new product under its NbR brand https://www.symphonyenvironmental.com/natural-biodegradable-resin/ to reduce the amount of fossil-derived material in plastic products.

 

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is certified according to ISO9001 and ISO14001.

 

Symphony participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

 

Further information on the Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv

 

See also Symphony on Instagram and Linkedin.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVDSAIDFIR
Date   Source Headline
2nd May 201410:00 amRNSAGM Statement
29th Apr 20149:00 amRNSAdditional Listing
8th Apr 201411:55 amRNSNotice of AGM
25th Mar 20147:00 amRNSFinal Results
21st Jan 20147:00 amRNSIssue of Equity
4th Dec 20137:00 amRNSAdditional Listing
7th Nov 20133:15 pmRNSGrant of options
28th Oct 20137:00 amRNSTrade show update
11th Sep 20137:00 amRNSHalf Yearly Report
28th Aug 20131:14 pmRNSExercise of Staff Options
21st Aug 20137:00 amRNSRe Contract
26th Jun 20133:44 pmRNSHolding(s) in Company
17th May 201310:30 amRNSResult of AGM
17th May 201310:15 amRNSAGM Statement
15th Apr 201311:04 amRNSNotice of AGM
27th Mar 20137:00 amRNSPreliminary Results
5th Mar 20137:00 amRNSHolding(s) in Company
20th Feb 20137:00 amRNSChange of Adviser
17th Jan 201310:47 amRNSSignificant Shareholding
16th Jan 20132:57 pmRNSDirector/PDMR Shareholding
16th Jan 20137:00 amRNSTrading Update
7th Dec 20128:52 amRNSDirector/PDMR Shareholding
6th Dec 201212:33 pmRNSDirector/PDMR Shareholding
5th Dec 20127:00 amRNSTrading Update
3rd Dec 201212:37 pmRNSNotificaiton of Major Interest in Shares TR1
3rd Dec 20127:00 amRNSHolding(s) in Company
11th Oct 201211:12 amRNSHolding(s) in Company
9th Oct 20121:00 pmRNSHolding(s) in Company
27th Sep 20127:00 amRNSHalf Yearly Report
17th Aug 201211:17 amRNSHolding(s) in Company
2nd Aug 20123:41 pmRNSExercise of Staff Options and Issue of Equity
29th May 201212:12 pmRNSHolding(s) in Company
23rd May 20127:00 amRNSNEW LCA PUTS d2w PLASTICS AHEAD
27th Apr 201210:31 amRNSResult of AGM
27th Apr 201210:18 amRNSAGM Statement
5th Apr 201210:20 amRNSDirector's Shareholding
30th Mar 20129:22 amRNSNotice of AGM
22nd Mar 20129:08 amRNSChina Exclusive Distribution Agreement
14th Mar 20127:00 amRNSPreliminary Results for the year to 31 Dec 2011
2nd Mar 20123:02 pmRNSHolding(s) in Company
16th Feb 20127:00 amRNSPlastics held at UAE ports
14th Feb 201210:52 amRNSHolding(s) in Company
7th Feb 20127:00 amRNSInternational Update - Mexico Presentation
13th Jan 20127:00 amRNSTrading Update
22nd Sep 20117:00 amRNSDirectors Dealings
20th Sep 20117:00 amRNSInterim Results
12th Sep 20117:00 amRNSTRADING & PRODUCT CLARIFICATION
6th Sep 201112:56 pmRNSInterim Results Date
17th Aug 201111:31 amRNSHolding(s) in Company
9th Aug 201112:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.